Grow Therapy raises US$150 million in Series D financing

Grow Therapy announced on March 4, 2026 that it raised US$150 million in Series D funding, co-led by existing backers TCV and Growth Equity at Goldman Sachs Alternatives. BCI and Menlo Ventures joined as new investors alongside other existing venture backers. Grow Therapy connects patients, therapists and psychiatric care providers and works with payers, employers and health systems to expand behavioral health access. The disclosed amount is the overall round size, not BCI's specific contribution. The announcement supports BCI's participation in growth-stage healthcare technology investments.